Folliculo-stellate cells (FSCs) are a non-endocrine population of sustentacular-like, star-shaped and follicle-forming cells, which contribute about 5-10% of elements from the anterior pituitary lobe. First identified with electron microscopy as non-hormone secreting accessory cells, light microscopy has revealed many of their cytophysiological features, and is known as positive for S-100 protein, a marker for FSCs. They are currently considered as functionally and phenotypically heterogeneous. Secretory cells are in close interconnection with this agranular functional units in an interactive endocrine networking. Due to FSCs communication with their endocrine neighbours, this opens the door to considering the pituitary as a cellular puzzle more ordered than the first thought. After a long period of pituitary research, many issues remain unsolved. In spite of many morphological and cytophysiological studies recently reported, a precise understanding of the major functions of FSCs in the pituitary gland remains unknown. New studies about the origin and differentiation of FSCs are expected to provide many relevant answers with respect to the debate about physiopathology of the pituitary gland. Here we review the characteristics of FSCs and their uncertain functions in the adenohypophysis, with focus on the present research points that we consider fundamental, such as their importance as stem cells, in the process of maturation and aging, and in the pathogenesis of pituitary tumors.
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Folliculo-stellate cells, S-100 protein, Pituitary tumor is a smaller avascular zone rough and poorly defined in humans (it regresses at about the 15 th week of gestation and become absent from the adult human pituitary gland). The pituitary gland is constituted by granule cells producing specific hormones that act by controlling the growth (growth hormone-GH-), lactation (prolactin-PRL-), thyroid function (triiodothyronine-T3-and thyroxine-T4-), adrenal function (adrenocorticotropic hormone-ACTH-) and gonadal function (follicle-stimulating hormone-FSH-and luteinizing hormone-LH-) [2] . Additionally, the neurons that are part of the posterior pituitary secrete vasopressin (antidiuretic hormone-ADH-), which is the hormone involved in maintaining water balance, and oxytocin, that play a role in uterine contraction and lactation. The negative feedback loop is the basic mechanism for controlling all endocrine glands [3] . These hormonal cells (granular) are associated with non-hormonal cells (agranular), of which the folliculo-stellate cells (FSCs) are the highest number [4] .
FSCs are primarily non-hormone secreting accessory elements which contribute about 5-10% of cells from the anterior pituitary [5] . These non-secreting cells clearly contribute to the regulation and maintenance of the population of hormonal cells, by delivering stimulating factors and inhibitors of the hypothalamus and to transport secretory products from the gland [6] .
Since the identification of the FSCs to nowadays, many features and functions have been identified. Here we review the characteristics of FSCs and their uncertain functions in the adenohypophysis, with focus on the present research points that we consider fundamental, such as their importance as stem cells, in the process of maturation and aging, and in the pathogenesis of pituitary tumors.
Introduction
The pituitary gland (pituitary) is a complex endocrine regulator, small but still fundamental to the human body. It is an intermediary body from the signal exchanges between the hypothalamus and peripheral organs, with important functions in physiological processes such as growth, reproduction, metabolism and immune response. Located in the sella turcica, has anteriorly the tubercle of the saddle and the optic chiasm, posteriorly the dorsum sellae and the brainstem and superiorly the hypothalamus [1] . Anatomically and functionally, this gland owns two lobes: the adenohypophysis (anterior pituitary-divided into two regions: pars tuberalis and pars distalis), which derives from the ectoderm and secretes hormones, and neurohypophysis (posterior pituitary-pars nervosa) derived from hypothalamic neuronal axons. A third lobe (pars intermedia)
Morphology
The first cells of the anterior pituitary where it a large-scale network organization was shown to exist were the FSCs [6] . In 1957, interdigitated configuration of many cells was observed in the anterior pituitary gland. The FSCs has been reported and described as adrenocorticotroph-like cells without secretory granules and arranged around the follicles [8] . In 1972, Vila-Porcile, based on their star-like morphology and their ability to form structures around the acini, named these cells as folliculo-stellate cells [9] .
Follicles are found throughout the adenohypophysis as lumens that are lined mainly by agranular or poorly granulated cells joined at their apex by junctional complexes. Traditionally, the polygonal cells surrounding these follicles, with long cytoplasmic processes were named follicular cells (FC) [10] . They stain for cytokeratins and are often observed around areas of necrosis [11] . On the other hand, folliculostellate (FS) cells are a specific subtype of cell in the normal human pituitary gland with immunoreactivity for S-100 protein [11] [12] [13] . These cells are agranular and do not exhibit immunoreactivity for the classic adenohypophysial hormones. They have a characteristic stellate morphology. Because of confusion with the FC, some authors have suggested that these cells should be called "stellate cells" [13] . Both were mostly considered to be supporting structures for the endocrine cells, but neither their origin nor their functional significance is well understood [5, 11, 14, 15] .
Due to the fact that FSCs are not endocrine cells, immunohistochemical detection with an antibody against a specific hormone cannot be used. This made it difficult to study FSCs and its research delayed compared to pituitary cells that are producing hormones. Many characteristics of FSCs remained unknown until the S-100 protein (S-100) was considered a cell marker [16] . S-100 is a calcium flux regulator protein which was first isolated from the central nervous system (CNS) [17] . Indeed, S-100 has been a powerful tool that allows FSCs viewing under an optical microscope [16] ( Figure 1 ). These cells are also positive for glial fibrillary acidic protein (GFAP) suggesting that this cell type may represent an astrocyte-or microglia-like cell type [1] . Several authors cited by Perez-Castro, et al. [1] , consider this hypothesis by their phagocytic capabilities and glia-like supportive functions within the pituitary, which are involved in the regulation of ion homeostasis, water transport and protection from damage caused by irradiation or free radical. Several studies were made using cell counts in order to assess the specificity of these immunohistochemical markers, but many inconsistencies were found across studies, which led to the absence of real progress on the nature and physiological role of FSCs.
Horvath and Kovacs [18] consider that S-100 and GFAP are human FSC markers only in limited contexts. These authors believe that none of the markers is suitable for quantification, and the sequence of the second marker expression cannot be unequivocally determined by cell morphology. Sands, et al. [19] reported that S-100 serves as a neurotrophic and glial maturation factor in the CNS that has also been detected in some types of pituitary cells during fetal growth.
Another way to define the FSCs is by absorbing the fluorescence of the peptide SS-Ala-Lys-Ne-AMCA (AMCA) by means of specific proton pump cell [20] . Taking advantage of selective absorption of AMCA, it was possible to confirm the organization of the FSCs in a 3D anatomical network [9] .
Functions
The early stage of development and organization of the FSCs has not been thoroughly investigated. However, observations were subsequently made in adult FSCs, and it was demonstrated that they form an excitable network [21] . Immunohistochemical and ultrastructural studies have shown that FSCs form a network within the anterior pituitary in which the cellular extensions of this cells are connected among each other mechanically and functionally through desmosomes and gap junctions (small pores that permit the intercellular exchange of molecules smaller than 1,000 Da), respectively.
According to Le Tissier, et al. [6] the intrinsic excitability of FSCs and expression of connexin 43, a peptide marker of gap junctions, both between themselves and with endocrine cells suggests that FSCs might play a role in the coordination activity in groups of cells from the endocrine system in a local or distal level, besides facilitating through the gap junctions the transmission signal the hypothalamic neurons that project to the pars tuberalis. Another function of the FSCs is related to pituitary functional plasticity that can be inferred from the modification of the number of gap junctions, and its morphological relationship with altered hormonal cells in response to physiological changes [6] .
In order to perform different functions, FSCs produce a range of growth factors that modulate and alter the function of the endocrine pituitary cells: the interleukin-6 (IL-6) [22] [23] [24] , the vascular endothelial growth factor (VEGF) [25] , the basic fibroblast growth factor (FGF-2) [26] and annexin-1 [27] , and express receptors for pituitary hormones [28] , suggesting a role of these cells in the mechanism of "short-feedback loop" in addition to hormonal cell modulation [6] .
Clues to FSC function should also be able to be gleaned from the morphological similarities they share with brain astrocytes, dendritic cells in the lymph tissue, Langerhans cells of the skin, sustentacular cells in the adrenal gland and Sertoli cells in the testis. Interestingly, all of these cells are positive for the S-100 protein [4] . For example, they are believed to have a supportive role similar to that played by the S-100-positive sustentacular cells of the adrenal medulla and paraganglia.
FSCs-Stem cells in the adult?
Inoue, et al. [4] quotes several authors on the possibility of FSCs being a type of stem cells with the potential to differentiate into endocrine cells. Recent studies were able to describe a population of cells with stem cell characteristics in the adult rat pituitary [29] [30] [31] . It was found that these cells may have the capacity for selfrenewal, being capable of differentiating into all types of anterior pituitary hormones cells [29, 30] . However, the process is not uniform and it was found that the adult positive cells are identified by Sox2 transcription factor (core transcription factor in maintaining the selfrenewal and pluripotency of the stem cells), which may represent a distinct population compared to the embryo and newborn [32] , and are mainly found in the crevice that separates the anterior lobe and intermediate but also scattered in the anterior lobe of the pituitary gland [33] . It is necessary to highlight the fact that the transcription factor Sox2 expressed in all cells of Rathke's pouch, the structure of which eventually gives rise to the anterior pituitary [34] .
The importance of these findings relates to the fact that the stem cells, after the renewal of the pituitary gland and cell response to physiological changes, are also involved in repairing damage to pituitary cells [35, 36] . The nature of the signals that drive their proliferation and differentiation into different cell types is not clear. An in vitro system to study the differentiation of stem cells in pituitary cells [37] has provided important information about the factors required for the process. Notably, embryonic stem cell can also be induced to differentiate into structures that resemble either of Rathke's pouch, as they have the ability to produce pituitary hormones [37] . The organization of Sox2 positive cells was described [38] , showing that the cells that line the cleft have the ability to contact with the cells dispersed within the lobe. This organization suggests that the long-range communication between these putative stem cells may be important in determining whether differentiation pathways, proliferation, or maintenance of stem cell characteristics.
Nolan and Levy [39] through studies in rats suggest that the differentiated cells may be sensitive to the size of their population and choose to differentiate into stem cells, however the whole mechanism is still unclear. An interesting hypothesis is that the organization of the "network" is responsible with the control of the cell population and the presence of multiple populations can provide a mechanism to trigger the differentiation of stem cells [6] .
Until the present, several studies support the existence of multipotent stem cells in the adult pituitary, but still not much is known about its function and significance because not all of them are in complete agreement. Bilezikjian, et al. [14] and Vankelecom [40] supposed that FSCs represent anterior pituitary stem cells.
According to Vankelecom, et al. [41] , a number of adult tissues are able to regenerate cells after destruction by physical or chemical impact, as in muscle tissue after injury or toxin injection. In other organs, involving stem cells is less clear in the repair or present only under certain conditions, as in liver due to illness or chemical attacks. It should be noted that there are many disease states where tissues are committed and if any response of stem cells, they may not be able to fully repair the tissue: the neural-stem cells are not able to restore the damages of degenerative disease (e.g. Parkinson's disease) and cardiac stem cells do not address the damage caused by myocardial infarction. The adult pituitary shows regenerative capabilities, but the mechanisms and the contribution of stem cells may differ by the degree and nature of the condition and the type of cell affected. According to this author there are issues that need to be explored: clarify whether these processes also occur in the pituitary disease conditions (e.g. Sheehan syndrome, hypophysitis), or after tissue damage by tumor resection or irradiation [41] . Although the functional significance of cells in stem-cell homeostasis of adult pituitary, the potential recovery of an injury, and deficits endocrine tumor pathogenesis have not been formally established. FSCs are found in large numbers in the compressed adenohypophysis at the periphery of adenomas and other pituitary lesions, such as abscesses and amyloid deposits, and in the residual hypophysis after surgery, but not adjacent to metastatic tumor deposits, infarcts, or Rathke cleft cysts [42] , which could explain the fact that the adenohypophysis does not undergo regeneration after partial infarction or resection.
FSCs and aging process
Some investigators supposed that FSCs may be involved in catabolic and trophic processes and with the transport of macromolecules. Previous studies indicated that the FSCs can be used to modulate hormone production and secretion in anterior pituitary through local paracrine actions [15, 43] . For this purpose, the interdigitations and the hormone producing cells can endure the presence of intercellular communication. Herkenham [44] suggests a role for the FSCs in a two-way communication between the immune and endocrine systems. This author reported that the origin of these non-hormone secreting anterior pituitary interstitial cells, according to their markers expression might be neuroectodermal and also possibly be glial in nature [44] . On the other hand, their phagocytic capacities, IL-6 secretion, and the fact that they share some immunohistochemical, ultrastructural and functional characteristics with lymphoid dendritic cells, suggests that probably their subpopulation could be derived from the monocyte-dendritic cells-macrophage lineage [45] . FSCs act as phagocytes of both cellular debris and apoptotic bodies, sharing properties with dendritic cells and also with macrophages, which support kinship between them and cells of the mononuclear phagocytic system [44, 46] .
Although the anterior pituitary is very important to maintain homeostasis of the human body, studies on their structural changes during the aging process are scarce. Sano, et al. [47] described some of these changes by assessing the changes related to age through the connective tissue analysis of the anterior pituitary and endocrine cells using histologic analysis and semi-quantitative methods.
However, there is a lack of data in the literature on aging changes in the FSCs and those that have been conducted using animal resources and obtained conflicting results [48] . Cónsole, et al. [49] evaluated the number of anterior pituitary cells S-100 positive during the aging process. This study showed a progressive decrease in FSCs connected to age in old and senescent rats (20 months and 29 months, respectively) compared to young (3 months). The analysis of morphometric parameters showed a significant decrease on its volume and cell density in the old and senescent rats compared to young in both genders.
Several studies have found approaches, as well as the presence of distinct levels of FSCs, increased during the postnatal life, and while some other studies have shown increased FSCs associated with age [45] .
Pavlovic, et al. [48] before the results lifted a question: If there is an increase with age, which could be the possible causes and consequences for the function of the anterior pituitary? Based on literature data, they conducted a study to quantify the FSCs in the anterior pituitary samples at different ages and in a roundabout way tried to establish its possible impact on the functioning of the anterior pituitary gland, during human aging. They concluded that FSCs increases its presence in the human anterior pituitary during the aging process. However, this increase is only significant in earlier cases, and perhaps taken together with changes related to age of the immune system, and characterized by chronic inflammatory condition of low quality and high levels of blood cytokines present in these cases. The above conditions can stimulate FSCs to proliferate and exhibit their paracrine actions in endocrine cells of the anterior pituitary and, ultimately, participate in aging changes of the hypothalamic-pituitary axis. Therefore, future studies should include, in addition to quantitation of FSCs, an appropriate biochemical and/ or immunohistochemical simultaneous analysis of levels of their products originated from paracrine function, in cases with different ages.
FSCs and pituitary tumors
Pituitary tumors are common in humans, and might cause various pathological complications such as growth disorders, sexual dysfunction, infertility, obesity, metabolic and mood disorders [50] . The tumors may arise from any cell of the anterior pituitary [2] . Pituitary adenomas (PA) are quite common and have been reported to occur in about 15-20% of the general population, a third of which is clinically significant [51, 52] . Most PA correspond to primary tumors that have a slow growth, and various hormonal and proliferative behaviour [50] .
We can find an extensive type of endocrine symptoms resulting from hormonal hypersecretion, but sometimes the space occupied by the tumor itself, particularly the rapidly growing causing an intracranial mass, may cause other problems such as decreased secretion of some hormones, visual disturbances, headache and sleep problems [2] . In addition to the clinical (functional) and radiological classification may also be classified histologically, which allows to redefine the hormonal nature of the adenomas [53] .
The progression mechanism of PA in more aggressive and invasive tumors is still unclear, and it has not been possible yet to find a marker that allows assisting the clinician on its prognosis. It is in this very specific point of the pathology of PA that Fauquier, et al. [54] refers to FSCs as supporting cells, with a dense network and decisive roles in the coordination of cellular activity, as a determining factor not only at physiological but also pathological level. Some authors indicate that there are certain endocrine tumors (pheochromocytomas or paragangliomas) where the reduction or absence of these sustentacular cells indicates a worse prognosis than when they are present, which is suggestive of their metastatic potential [55, 56] . But here, once again, the results are not consistent. Recently, a study conducted by Tortosa, et al. [57] found that the predictive factor of tumor aggressiveness for PA, is not represented by a low value of S-100 in FSCs, not allowing the selection of patients for intensive post-operative treatment. This study shows that the labelling index for S-100 protein cannot be used as a prognostic factor of aggressive behaviour for pituitary tumors. Reminding that a nonnegligible part of PA are not ultimately amenable to cure by either conventional pharmacotherapy or surgery, perhaps FSCs may offer some solutions in the pathogenesis of PA.
Special mention for the spindle cell oncocytoma (SCO), an unusual and controversial tumor. This is a spindled to epithelioid, oncocytic, non-neuroendocrine neoplasm of the pituitary gland [58] . It was first reported in 2002 by Roncaroli [59] , who proposed that the origin of this tumor was in the FSCs of the anterior pituitary. Till the date, the histogenesis of SCO remains unresolved. Initially, a derivation from FSCs of the adenohypophysis was postulated on the basis of the immunoprofile (in particular galectin-3 and annexin A1 expression) and ultrastructural features. However, finding that not only pituicytomas, but also granular cell tumors of the sellar region and SCO express the nuclear transcription factor TTF1, like pituicytes of the developing and mature neurohypophysis, suggests a pituicyte derivation [60] . So, the difference between this tumor and the tumor called "pituicytoma", which is attributed to stromal cells of the posterior lobe, is not clear.
Conclusion
FSCs are non-hormone secreting accessory cells that have an important role in the integration of information on the anterior pituitary auto/paracrine loops. Thus, this cell networking within the pituitary could have a privileged role in coordinating the activities of distant cells in both physiological and pathological conditions. However, the physiopathological role of the intrapituitary FSC network for the regulation of the anterior pituitary is still poorly understood. After a long period of pituitary research, recent evidence has been involving FSCs with facets of adenohypophyseal machinery as manifold as paracrine regulation, cellular turnover, and neuroimmune crosstalk, but many issues remain unsolved. New studies about the origin and differentiation of FSCs are expected to provide several answers with respect to the debate about physiopathology of the pituitary gland.
